验证[18F]-FDG PET-CT低剂量CT扫描评估骨骼肌质量与诊断性颈部CT扫描的对比
本研究前瞻性纳入233例头颈癌患者,回顾性勾画第三颈椎水平的骨骼肌并计算骨骼肌指数(SMI),比较[18F]-FDG PET-CT低剂量颈部CT与诊断性颈部CT所测(低)SMI的一致性。结果显示两种模态间SMI一致性高(ICC>0.990,平均ΔSMI=-0.19 cm2/m2,κ=0.911),手臂位置不影响一致性;结论认为(低)SMI不受CT采集参数、手臂位置和观察者影响。
要点
- 基于[18F]-FDG PET-CT低剂量CT与诊断性颈部CT测量的(低)SMI一致性高(κ=0.911)。
- 两种模态间SMI平均差值为-0.19 cm2/m2,未见明显偏倚。
- 手臂位置不影响(低)SMI的高一致性。
核心结论
- 以(低)SMI测量的骨骼肌质量在诊断性颈部CT与[18F]-FDG PET-CT低剂量颈部CT之间、不同手臂位置及不同观察者间保持一致。
研究设计与样本
- 前瞻性纳入OncoLifeS数据生物库中同时具有颈部诊断性CT和[18F]-FDG PET-CT的头颈癌患者,回顾性在第三颈椎水平勾画骨骼肌并计算(低)SMI(cm2/m2),以诊断性颈部CT的(低)SMI为参考标准,行组内相关系数(ICC)、Bland-Altman图和Cohen's Kappa分析。
- 队列样本量n=233,平均年龄66.2±12.8岁,男性占74.2%。
主要发现
- 观察者间信度极好(ICC>0.990,95%CI 0.975-0.996,p<0.001)。
- Bland-Altman图显示两种模态间SMI一致性高,平均ΔSMI=-0.19 cm2/m2,无明显偏倚。
- Cohen's Kappa分析显示两种模态间低SMI几乎完全一致(κ=0.911,p<0.001)。
- 手臂位置不影响(低)SMI的高一致性。
关键数值与推荐
- 观察者间信度ICC>0.990(95%CI 0.975-0.996,p<0.001)。
- 两种模态间SMI平均ΔSMI=-0.19 cm2/m2。
- 低SMI一致性Cohen's Kappa κ=0.911(p<0.001)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: Radiologically defined sarcopenia, or a low skeletal muscle index (SMI), is an emerging biomarker for adverse clinical outcomes in head and neck cancer (HNC) patients. Recently, SMI measurements have been validated at the level of the third cervical vertebra (C3) on diagnostic neck CT scans but are not yet validated on low-dose (LD) neck CT scans from the [18F]-FDG PET-CT. This hampers SMI analysis in HNC patients without a diagnostic neck CT but with a [18F]-FDG PET-CT scan. Therefore, the aim was to study whether (low) SMI based on LD CT scan from [18F]-FDG PET-CT is comparable to those derived from diagnostic neck CT scans. METHODS: HNC patients with both diagnostic CT and [18F]-FDG PET-CT of the neck were prospectively included into the OncoLifeS data-biobank. Skeletal muscle was retrospectively delineated at the level of the third cervical vertebra (C3), and (low) SMI (cm2/m2) was calculated for diagnostic and LD neck CTs. (Low) SMI from the diagnostic neck CT was considered the reference standard. Intra-class correlation coefficient (ICC), Bland-Altman plots, and Cohen's Kappa analysis were performed. RESULTS: The cohort (n = 233) mean age was 66.2 ± 12.8 years, and 74.2% of patients were male. Inter-rater reliability was excellent (ICC > 0.990, 95% confidence interval 0.975-0.996, p < 0.001). The agreement of SMI between both modalities was high according to the Bland-Altman plot (mean ΔSMI = - 0.19 cm2/m2), and there was no substantial bias. Cohen's Kappa analysis showed an almost perfect agreement of low SMI between the two modalities (κ = 0.911, p < 0.001). The position of arms didn't affect the high agreement of (low) SMI. CONCLUSION: Skeletal muscle mass, as measured with (low) SMI, remains constant irrespective of CT acquisition parameters (diagnostic neck CT scans versus LD neck scans of the [18F]-FDG PET-CT scan), positioning of arms, and observers. These findings contribute to the construction of a clinically useful radiological biomarker for SMI and therefore identify patients at risk for adverse clinical outcomes.
引用
- Zwart AT, Cavalheiro VJ, Lamers MJ, et al. The validation of low-dose CT scans from the [18F]-FDG PET-CT scan to assess skeletal muscle mass in comparison with diagnostic neck CT scans. Eur J Nucl Med Mol Imaging. 2023. PMID: 36781423. doi:10.1007/s00259-023-06117-3
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。